CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Lilly to buy TED startup Merida Biosciences in its 13th acquisition of 2026

Positive
AI Analysis

Summary

Eli Lilly is acquiring Merida Biosciences for up to $2.875 billion in its 13th acquisition of 2026, strengthening its immunology portfolio.

Importance:7/10
Sentiment:
0.60
M&Aimmunologyacquisition
Related Companies

Read the original article

Published by Endpoints News on August 31, 2026 1:47 PM

Read Original